Kliniken Beelitz GmbH /ID# 215403
Beelitz-Heilstätten 14547
0 studies enrolling now · 1 studies all time
What they study most
Parkinson's Disease (PD)
Studies at this site
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
— Completed